港股異動 | 創建集團控股(1609.HK)暴跌近62% 聯交所稱公司股份將被暫停交易
格隆匯6月7日丨創建集團控股(1609.HK)午後狂瀉,現報2.68港元,跌近62%,盤中跌幅一度達到78%,低見1.5港元創約三年半新低,成交額放大至1.78億港元,最新總市值29億港元。創建集團控股今早公佈,公司已收到聯交所發出的函件,聯交所認為,然過去36個月控制權並無變動,但在公司於今年1月向公司前控股股東出售創健集團有限公司後,公司的主營業務已變更為提供物流相關服務,且全部均於27個月內進行。此外,新能源汽車與物流及融資租賃業務並不符合第8.05條的新上市要求。聯交所認為,鑑於出售事項已完成,公司不再適合上市,公司股份將被暫停交易。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.